Antihypertensive drugs may offer protection against Alzheimer’s
June 24th, 2010 - 5:55 pm ICT by ANIWashington, June 24 (ANI): Carvedilol, the drug currently prescribed for the treatment of hypertension, may lessen the degenerative impact of Alzheimer’s disease and promote healthy memory functions, scientists at Mount Sinai School of Medicine have found.
“These studies are certainly very exciting, and suggest for the first time that certain antihypertensive drugs already available to the public may independently influence memory functions while reducing degenerative pathological features of the Alzheimer’s disease brain,” said study author Giulio Maria Pasinetti, from Mount Sinai School of Medicine.
Dr. Pasinetti’s team found for the first time that carvedilol, a blood pressure lowering agent, is capable of exerting activities that significantly reduce Alzheimer’s disease-type brain and memory degeneration.
This benefit was achieved without blood pressure lowering activity in mice genetically modified to develop Alzheimer’s disease brain degeneration and memory impairment. These data were published in Neurobiology of Aging.
In a second study published in the Journal of Alzheimer’s Disease, the research team led by Dr. Pasinetti assessed how mice learned new tasks and information and recall of past information chemically stored in the brain.
They found that carvedilol treatment was capable of promoting memory function, based on assessments of learning new tasks and information and recall of past information, which is already chemically stored in the brain.
In the study, one group of mice received carvedilol treatment and the other group did not. The scientists conducted behavioral and learning tests with each group of mice, and determined that it took the mice in the carvedilol significantly less time to remember tasks than the other group.
“Ongoing clinical research is in progress to test the benefits of carvedilol, which may prove to be an effective agent in the treatment of symptoms of Alzheimer’s disease. We look forward to further studying this drug in the human population,” said Dr. Pasinetti. (ANI)
- Grape seed extracts could protect against Alzheimer's - Jul 16, 2011
- Indications of Alzheimer's may be evident decades before first signs - Mar 29, 2011
- Brain cells prone to Alzheimer's attack grown in lab - Mar 04, 2011
- New gene could explain relationship between diabetes, Alzheimer's - Oct 13, 2010
- 5 more genes behind Alzheimer's disease risk identified - Apr 04, 2011
- The real culprit behind Alzheimer's disease - Apr 28, 2010
- Potential therapeutic target for improving long-term memory identified - Jan 27, 2011
- New study sheds light on brain's inherent ability to focus on learning - Dec 09, 2010
- Memory Loss Due To Alzheimer's Disease Can Be Cured By Sniffing Insulin: Study - Jul 19, 2010
- Brain chemical boosts memory, could treat Alzheimer's - Jan 27, 2011
- Reversing Alzheimer's gene 'blockade' restores memory - Mar 01, 2012
- New discovery shows promise against Parkinson's, Alzheimer's - Dec 08, 2010
- Novel study offers hope for new class of Alzheimer's drugs - Oct 19, 2010
- Scientists isolate protein that sculpts memory - Sep 29, 2011
- Rheumatoid arthritis may protect against Alzheimer's disease - Aug 23, 2010
Tags: alzheimer, antihypertensive drugs, blood pressure, brain degeneration, carvedilol, clinical research, disease brain, hypertension, june 24, memory function, memory functions, memory impairment, mice, mount sinai school, mount sinai school of medicine, neurobiology, pathological features, school of medicine, study author, treatment of hypertension